Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 76890

7 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
March 24, 2017
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Qinhuangdao Zizhu Pharmaceutical, Co.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

7 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 7

Estradiol Micronized Bulk, Rx only, For Prescription Compounding, Manufactured by Qinhuangdao Zizhu Pharmaceutical Co., Ltd, Qinhuangdao 066004, China (NDC 44132-001-01) (44132-001-06)

D-0654-2017
Recall number
D-0654-2017
Initiated
March 24, 2017
Classification
Class II
Status
Terminated
Quantity
N/A

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
cGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations; lack of quality assurance.

Code information

Batch 80001512002 to Batch 80801604003, exp 10/22/2017 through 3/30/3018

Distribution pattern

Product distributed to NY, TX, SC, CO, MN and NJ

drug · product 2 of 7

Estradiol Non-Micronized, USP, Bulk, Rx only, For Prescription Compounding, Manufactured by Qinhuangdao Zizhu Pharmaceutical Co., Ltd, Qinhuangdao 066004, China

D-0655-2017
Recall number
D-0655-2017
Initiated
March 24, 2017
Classification
Class II
Status
Terminated
Quantity
N/A

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
cGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations; lack of quality assurance.

Code information

Batch 80701510001 to Batch 80001607002, exp 10/22/2017 through 7/5/2018

Distribution pattern

Product distributed to NY, TX, SC, CO, MN and NJ

drug · product 3 of 7

Estriol Micronized, USP, Bulk, Rx only, For Prescription Compounding, Manufactured by Qinhuangdao Zizhu Pharmaceutical Co., Ltd, Qinhuangdao 066004, China 44132-007-06

D-0656-2017
Recall number
D-0656-2017
Initiated
March 24, 2017
Classification
Class II
Status
Terminated
Quantity
N/A

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
cGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations; lack of quality assurance.

Code information

Batch 81801504002 to 81801701003, exp 4/12/2017 through 1/19/2019

Distribution pattern

Product distributed to NY, TX, SC, CO, MN and NJ

drug · product 4 of 7

Estrone Micronized, USP, Bulk, Rx only, For Prescription Compounding, Manufactured by Qinhuangdao Zizhu Pharmaceutical Co., Ltd., Qinhuangdao 066004, China (NDC 44132-003-04) (NDC 44132-003-02)(NDC 44132-003-06)

D-0657-2017
Recall number
D-0657-2017
Initiated
March 24, 2017
Classification
Class II
Status
Terminated
Quantity
N/A

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
cGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations; lack of quality assurance.

Code information

Batch 82801505001 to 82801606001, exp 5/4/2017 through 5/19/2018

Distribution pattern

Product distributed to NY, TX, SC, CO, MN and NJ

drug · product 5 of 7

Testosterone Micronized, Bulk, Rx only, For Prescription Compounding, Manufactured by Qinhuangdao Zizhu Pharmaceutical Co., Ltd., Qinhuangdao 066004, China (NDC 44132-006-06)

D-0658-2017
Recall number
D-0658-2017
Initiated
March 24, 2017
Classification
Class II
Status
Terminated
Quantity
N/A

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
cGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations; lack of quality assurance.

Code information

Batch 78801507001 to 78901612003, exp 6/22/2017 through 11/21/2018

Distribution pattern

Product distributed to NY, TX, SC, CO, MN and NJ

drug · product 6 of 7

Ethinyl Estradiol Micronized, USP, Bulk, Rx only, For Prescription Compounding, Manufactured by Qinhuangdao Zizhu Pharmaceutical Co., Ltd, Qinhuangdao 066004, China (NDC 44132-002-05)

D-0659-2017
Recall number
D-0659-2017
Initiated
March 24, 2017
Classification
Class II
Status
Terminated
Quantity
N/A

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
cGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations; lack of quality assurance.

Code information

Batch 73801506007 to 73801603001, exp 5/31/2017 through 1/15/2018

Distribution pattern

Product distributed to NY, TX, SC, CO, MN and NJ

drug · product 7 of 7

Levonorgestrel Non-Micronized, USP, Bulk, Rx only, For Prescription Compounding, Manufactured by Qinhuangdao Zizhu Pharmaceutical Co., Ltd., Qinhuangdao 066004, China (NDC 44132-012-01),

D-0660-2017
Recall number
D-0660-2017
Initiated
March 24, 2017
Classification
Class II
Status
Terminated
Quantity
N/A

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
cGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations; lack of quality assurance.

Code information

Batch 70001602009, 2/21/2021

Distribution pattern

Product distributed to NY, TX, SC, CO, MN and NJ